Biomedicina predictiva e investigación traslacional de las enfermedades respiratorias, cardiovasculares y metabólicas
BIOPRE
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Príncipe de Asturias (19)
2024
-
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
Leukemia
-
Improvement of Early Outcomes in Type A Acute Aortic Syndrome After an Aorta Code Implementation
Annals of Thoracic Surgery, Vol. 117, Núm. 4, pp. 770-778
-
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology
2023
-
Tuberculosis in Spain: An opinion paper
Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583
2021
-
Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study
European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28
2019
-
Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia
Human Mutation, Vol. 40, Núm. 8, pp. 1181-1190
2018
-
Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes
Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567
-
Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis
Respiration, Vol. 96, Núm. 5, pp. 406-416
-
Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study
Archivos de Bronconeumologia, Vol. 54, Núm. 5, pp. 270-279
2017
-
Clinical audit of COPD in outpatient respiratory clinics in Spain: The EPOCONSUL study
International Journal of COPD, Vol. 12, pp. 417-426
-
The variability of respiratory symptoms and associated factors in COPD
Respiratory Medicine, Vol. 129, pp. 165-172
2016
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
-
Perfil clínico y mortalidad a 90 días de los pacientes centenarios atendidos en servicios de urgencias hospitalarios
Revista Espanola de Geriatria y Gerontologia, Vol. 51, Núm. 4, pp. 196-200
2010
-
Study of Prevalence and Attitudes on Smoking in Patients on Continuous Home Oxygen Therapy. Toma Study
Archivos de Bronconeumologia, Vol. 46, Núm. 11, pp. 580-586
-
Tabaquismo
Revista de Patologia Respiratoria, Vol. 13, Núm. 2, pp. 97-99
2008
-
Efecto de AM3 en la calidad de vida de pacientes con enfermedad pulmonar obstructiva crónica en subgrupos de riesgo
Medicina Clinica, Vol. 130, Núm. 18, pp. 688-692
2006
-
Treatment with AM3 restores defective T-cell function in COPD patients
Chest, Vol. 129, Núm. 3, pp. 527-535
2004
-
Efecto del inmunomodulador AM3 sobre las agudizaciones en enfermos con bronquitis crónica: Una revisión sistemática de estudios controlados
Revista Clinica Espanola, Vol. 204, Núm. 9, pp. 466-471
2001
-
Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón)
American Journal of Respiratory and Critical Care Medicine, Vol. 163, Núm. 7, pp. 1578-1583